Publication:
Effects of human endothelial gene polymorphisms on cellular responses to hyperglycaemia: Role of NOS3 (Glu298Asp) and ACE (I/D) polymorphisms

dc.contributor.authorJoshi M.S.
dc.contributor.authorWattanapitayakul S.
dc.contributor.authorSchanbacher B.L.
dc.contributor.authorBauer J.A.
dc.date.accessioned2021-04-05T03:34:58Z
dc.date.available2021-04-05T03:34:58Z
dc.date.issued2011
dc.date.issuedBE2554
dc.description.abstractThe functional relevance of NOS3 and ACE genetic variations to endothelial cell function is largely unstudied. Here we tested the functional relevance of the NOS3 (Glu298Asp) polymorphism and ACE (I/D) polymorphism in endothelial cells in vitro. Our hypothesis was that these genetic polymorphisms alter endothelial cell sensitivity to glucose and 3-nitrotyrosine (3NT). Genotyped HUVECs were incubated with glucose, free 3NT or a combination of these two toxicants. Significant differences in glucose-induced cell death and free 3NT-induced cell death were observed among the NOS3 genotypes. Combined glucose/3NT caused increased toxicity among the NOS3 genotypes. No differences were observed among the ACE genotypes in their responses to glucose/3NT. These data demonstrate that the NOS3 genotype may be an important predictor of, or be mechanistically involved in, endothelial vulnerability, whereas the ACE I/D genotype is apparently less important. Thus this NOS3 genetic variation may play a role in vulnerability to endothelium-dependent diabetic vascular complications. © SAGE Publications 2011.
dc.format.mimetypeapplication/pdf
dc.identifier.citationDiabetes and Vascular Disease Research. Vol 8, No.4 (2011), p.276-283
dc.identifier.doi10.1177/1479164111416679
dc.identifier.issn14791641
dc.identifier.other2-s2.0-80053058309
dc.identifier.urihttps://hdl.handle.net/20.500.14740/7234
dc.rights.holderมหาวิทยาลัยศรีนครินทรวิโรฒ
dc.subject.other3 nitrotyrosine
dc.subject.otherDipeptidyl carboxypeptidase
dc.subject.otherEndothelial nitric oxide synthase
dc.subject.otherGlucose
dc.subject.otherArticle
dc.subject.otherCell death
dc.subject.otherCell viability
dc.subject.otherCellular stress response
dc.subject.otherGenetic polymorphism
dc.subject.otherGenetic variability
dc.subject.otherGenotype
dc.subject.otherHuman
dc.subject.otherHuman cell
dc.subject.otherHuman cell culture
dc.subject.otherHyperglycemia
dc.subject.otherIn vitro study
dc.subject.otherUmbilical vein endothelial cell
dc.subject.otherCaveolin 1
dc.subject.otherCell Death
dc.subject.otherCells, Cultured
dc.subject.otherDiabetic Angiopathies
dc.subject.otherGenotype
dc.subject.otherGlucose
dc.subject.otherHuman Umbilical Vein Endothelial Cells
dc.subject.otherHumans
dc.subject.otherHyperglycemia
dc.subject.otherNitric Oxide Synthase Type III
dc.subject.otherNitrites
dc.subject.otherPeptidyl-Dipeptidase A
dc.subject.otherPhenotype
dc.subject.otherPhosphorylation
dc.subject.otherPolymorphism, Genetic
dc.subject.otherProto-Oncogene Proteins c-akt
dc.subject.otherTyrosine
dc.titleEffects of human endothelial gene polymorphisms on cellular responses to hyperglycaemia: Role of NOS3 (Glu298Asp) and ACE (I/D) polymorphisms
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-80053058309&doi=10.1177%2f1479164111416679&partnerID=40&md5=ef314d3a53012d3c76722432c8a500e2

Files